Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Denileukin diftitox

EU orphan designation number: EU/3/01/075   
Active ingredient: Denileukin diftitox
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: Eisai Limited
European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/12/2001 Orphan designation EMEA/OD/038/01 (2001)4110 of 11/12/2001
13/02/2004 Change of name and/or address of sponsor
27/03/2007 Transfer of orphan designation EMEA/OD/038/01/T/01 (2007)1449 of 23/03/2007
23/07/2009 Change of name and/or address of sponsor